(3-Bromo-5-fluoropyridin-2-yl)methanamine hydrochloride

Catalog No. :
ACFMHV425
CAS No. :
1257535-21-9
Molecular Formula :
C6H7BrClFN2
Molecular Weight :
241.49

IUPAC Name:(3-bromo-5-fluoropyridin-2-yl)methanamine hydrochloride

(3-Bromo-5-fluoropyridin-2-yl)methanamine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$85.00Login to see priceIn stockInquiry
250mg95%$135.00Login to see priceIn stockInquiry
1g95%$306.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3-Bromo-5-fluoropyridin-2-yl)methanamine hydrochloride
IUPAC Name(3-bromo-5-fluoropyridin-2-yl)methanamine hydrochloride
MDL No.MFCD17214199
Molecular FormulaC6H7BrClFN2
Molecular Weight241.49
SMILESFC1=CN=C(CN)C(Br)=C1.[H]Cl
InChI KeyQUYLODHOBQNZEV-UHFFFAOYSA-N
Synonym1257535-21-9 | (3-BROMO-5-FLUOROPYRIDIN-2-YL)METHANAMINE HYDROCHLORIDE | (3-bromo-5-fluoropyridin-2-yl)methanamine;hydrochloride | (3-Bromo-5-fluoropyridin-2-yl)methanamine HCl | 2-(Aminomethyl)-3-bromo-5-fluoropyridine hydrochloride | SCHEMBL23093360 | DTXSID2069418
CAS No.1257535-21-9
PubChem CID53395618

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACFMHV425 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACADHQ201 route compound structure diagram
    ACADHQ201950670-18-5 In Stock
  2. Then
  3. ACFMHV425 route product structure diagram
    ACFMHV4251257535-21-9 In Stock
Inquiry

2. ACFMHV425 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFMHV425 route product structure diagram
    ACFMHV4251257535-21-9 In Stock
Inquiry

Comments (0)